Joseph Elliot

Joseph Elliot is the current Chief Operating Officer at Inagene Diagnostics. Prior to this, they served as the President & CEO of ANRis Pharmaceuticals Inc. from September 2015 to February 2017. Joseph has also held the position of VP Product Development at Realist Pharma from August 2016 to December 2017.

Joseph Elliot has over 30 years of experience in the Life Sciences industry, with a focus on vaccines, immuno-oncology therapeutics, and manufacturing. Joseph holds a PhD in Medical Sciences from McMaster University. Under their leadership, Realist Pharma has developed a unique technology platform which addresses multiple oncology targets, each present in many different cancers. This platform has resulted in two programs, one pre-clinical vaccine program based on a novel class of patented small molecules and one complementary cell therapy program which is on the verge of entering the clinic.

Joseph Elliot has a Ph.D. in Medical Sciences from McMaster University and an M.Sc. in Biological Sciences from Brock University. Joseph also has a BSc in Biological Sciences from Brock University.

Their manager is Nancy White, Chief Executive Officer. They are on a team with Benjamin D. Pinder - Scientific Director, Sigrun Watson - VP Marketing and Sales, and Jeff Albin - Chief Financial Officer.